WEBVTT
00:00:05.200 --> 00:00:07.870
Welcome to the Latin medtech leaders podcast.
00:00:08.169 --> 00:00:13.210
This is a weekly conversation with med tech leaders who have succeeded in Latin America
00:00:13.970 --> 00:00:14.630
today.
00:00:14.660 --> 00:00:18.140
Our guest is curt Zeller EBA.
00:00:18.289 --> 00:00:20.480
Kirk, it's great to have you here today.
00:00:20.510 --> 00:00:22.070
Thank you for joining the show.
00:00:22.250 --> 00:00:22.609
Thank you.
00:00:22.611 --> 00:00:23.449
Happy to be here.
00:00:23.719 --> 00:00:24.859
Appreciate the opportunity.
00:00:25.250 --> 00:00:25.820
Oh sure.
00:00:26.120 --> 00:00:26.120
Correct.
00:00:26.359 --> 00:00:26.750
What it is hers.
00:00:26.760 --> 00:00:29.030
I mean Kirk is a very special guest.
00:00:29.469 --> 00:00:40.189
His probably being the only make the clutter right now off the has a doctorate degree in business with a specific concentration or emphasis in medical devices.
00:00:40.191 --> 00:00:47.149
So Kurt is very knowledgeable about medical technologies, how to expand markets without very in depth.
00:00:47.600 --> 00:00:49.399
Um, practical experience in Asia.
00:00:49.880 --> 00:00:57.590
He has over 25 years of medical device industry experience in sales and marketing, market development and business development in general.
00:00:58.310 --> 00:01:05.329
He has led and executed the launch of medical devices for neuro cardiac vascular spine and pulmonary technologies.
00:01:06.040 --> 00:01:13.120
Turk build the Micros business in Asia and successfully launch many medical devices in that featuring as well here.
00:01:13.560 --> 00:01:27.709
Cost spent much of his career luncheon devices, the bellow by Silicon Valley startups and he has studied business in seven countries including Japan, China and India and has spent 10 years of his lives working and studying in Japan.
00:01:28.069 --> 00:01:33.200
So he's quite a fascinating individual and I'm really, really honored to have you here on the show.
00:01:33.200 --> 00:01:37.250
And thank you again for joining our episode, the not tech leaders podcast.
00:01:37.930 --> 00:01:39.790
Thank you very much for the kind introduction.
00:01:40.349 --> 00:01:40.709
Sure.
00:01:40.710 --> 00:01:41.069
Kirk.
00:01:41.430 --> 00:01:46.049
Well let's get the conversation we started with your journey to Latin America.
00:01:46.109 --> 00:01:53.849
I know you have very good practical experience in Asia, Kirk, but how do you get involved with Latin America in your past positions?
00:01:54.250 --> 00:02:03.579
Yes, I started my career as you mentioned, working in Japan, working for distributors in Japan and my first exposure, Latin America really was only to a lot of international distributor meetings.
00:02:03.581 --> 00:02:09.009
So I was involved with a lot of products, mostly from the United States and Europe, you know, launching them in Japan.
00:02:09.010 --> 00:02:15.909
And so I'd find myself going to international distributor meetings each year and that's where I started getting exposure to Latin America.
00:02:15.911 --> 00:02:22.870
We would mostly be in those meetings talking about the issues in different regions and oftentimes a special, my role expanded beyond Japan.
00:02:22.871 --> 00:02:33.460
I saw a lot of similarities between the challenges that those folks were facing with the launching these products in Latin America and the ones that we were faced with and launching and several of the countries in Asia.
00:02:34.069 --> 00:02:34.520
Sure.
00:02:34.930 --> 00:02:35.379
Okay.
00:02:36.069 --> 00:02:45.189
And Kirk, what's your overall perception of Latin America as a place to conduct first thing, human clinical trials or to commercialize medical devices?
00:02:45.389 --> 00:02:49.199
I think it's getting a lot more attention these days than it probably was in the past.
00:02:49.200 --> 00:02:52.319
And I'm also running an ischemic stroke company.
00:02:52.620 --> 00:02:55.530
We're certainly planning to do first in man in Latin America.
00:02:55.860 --> 00:02:58.830
I think you and I have talked in previous conversations.
00:02:59.180 --> 00:03:07.099
I think the changes in Europe, particularly with the EU MDR implementation, it was really raised the barriers to entry for commercialization in Europe.
00:03:07.100 --> 00:03:15.620
And subsequently people I think are thinking about when it comes to first in man, other places to do first in man and how to segue that into commercial experience as well.
00:03:15.621 --> 00:03:21.560
So I think they'll certainly be more companies that we'll look to do first in man and early commercial work as well.
00:03:21.810 --> 00:03:32.810
I'm in Latin America and you know you mentioned in the intro about my academic research and at the time that I did it I was focused on European market entry strategies for venture capital finance, medical device companies.
00:03:32.811 --> 00:03:49.090
Looking really closely at everything from doing the early first and man work and the early commercial work and I think if I were at this point in 2019 doing a doctorate and looking to research, this is exactly the types of topics that I think I would be embracing for that research.
00:03:49.530 --> 00:03:56.889
And I think over time more companies are going to look to Latin America for first and men and some of the early commercialization as well.
00:03:57.460 --> 00:03:58.090
Very good.
00:03:58.150 --> 00:03:58.659
Excellent.
00:03:58.661 --> 00:04:05.889
I'm very happy to hear that you have a positive outlook in Latin America for first in human trials and early converse realization.
00:04:06.189 --> 00:04:11.969
What specific advantages do you see in Latin American Kirk that are appealing to
00:04:12.189 --> 00:04:17.829
medical device companies looking to do first in human trials or to sell their technologies in the region?
00:04:18.610 --> 00:04:44.649
I think you've got a lot of well-trained physicians when I've been working on looking at launching products in Latin America in the past and then a lot of physicians who were trained with some of the world renowned physicians in their specialty and then they go back to one of the Latin American countries and practice and I think those physicians bring that same level of expertise that you have at any of these leading centers in the u s and Europe, but you have a little bit lower barriers to getting that work done in Latin America.
00:04:44.651 --> 00:04:55.180
And I think over time as more work gets done there and the physicians get more exposure, hopefully we'll see a trend towards that gap between commercialization in the U S and Europe and Latin America.
00:04:55.269 --> 00:05:03.970
There often tends to be a pretty significant gap and hopefully over time as more and more companies do their early work in Latin America, they'll proceed with getting approvals and actually launching.
00:05:04.600 --> 00:05:04.899
Hmm.
00:05:05.050 --> 00:05:05.500
Very good.
00:05:05.949 --> 00:05:05.949
Alright.
00:05:06.430 --> 00:05:13.459
And what similarities do you see between Latin America and Asia, which is where you've done a lot of your work?
00:05:14.399 --> 00:05:19.259
Yeah, our farm certainly does focus predominantly on market access in the Asia Pacific region.
00:05:19.560 --> 00:05:21.329
I kind of feel like there are a lot of similarities.
00:05:21.331 --> 00:05:32.810
One is you have a few really big markets that you tend to put a lot of your commercial emphasis on while at the same time leveraging the infrastructure you have in the region to service to some other markets.
00:05:32.810 --> 00:05:43.269
So obviously if you're looking at Asia and in China or the dominants markets where it's somewhere, depending on the product line companies, probably 80 90% of their revenue comes from those two markets.
00:05:43.660 --> 00:05:49.759
But if you manage the business while you can also grow some of the other countries in the region profitably.
00:05:50.459 --> 00:05:50.459
Okay.
00:05:51.240 --> 00:06:05.459
I like to get your take on the suggested go to market strategy for Latin America, leveraging on your experience in Asia and also taking into account the similarities between the two markets.
00:06:05.939 --> 00:06:11.000
I usually see companies approaching Latin America in two fashions.
00:06:11.300 --> 00:06:24.319
One is a proactive and well thought out strategy where they create a market access plan for each country they are planning to enter in North America and the other is a barrier opportunistic or reactive approach.
00:06:24.529 --> 00:06:26.720
We're just wait for the shooter to contact them.
00:06:27.139 --> 00:06:30.920
They sign out of the publishing agreement and just let us shooter wrong.
00:06:31.370 --> 00:06:32.629
They show on their own.
00:06:33.279 --> 00:06:35.350
What do you think about these two strategies?
00:06:35.379 --> 00:06:41.980
What's your prefer way to enter the market in Asia or for the sake of the conversation about American?
00:06:42.259 --> 00:06:48.139
Yeah, so I think about Asia and particularly Japan being the largest market in Asia for most medical devices.
00:06:48.529 --> 00:06:55.639
We generally advocates the companies try to get the approvals in their own name and to be very deliberate in their distributor selection.
00:06:55.790 --> 00:07:18.230
And it's case by case, but I think our prescribed approach would really be to go out and find the right regulatory consultants and work closely and market access consultants and work closely with those firms to start from the perspective of which market should you enter and then work on getting into those markets and we usually don't suggest and just jumping out and getting any distributor that comes from the trade show.
00:07:18.500 --> 00:07:32.660
If the company has the budget to do it, we generally suggest that they get on the way with regulatory and all aspects where they have market entry and market access and do the distributor selection a little bit down the road and in the markets are from services.
00:07:32.990 --> 00:07:42.139
We know all the distributors and we can kind of give them a perspective on the strengths and weaknesses of each and help guide them through that process and through the due diligence.
00:07:42.141 --> 00:07:50.540
What of course happens in many cases, and I'm sure you've seen this a lot in your experience as well, is that people exhibited international or global trade shows.
00:07:50.540 --> 00:08:07.730
The distributor comes up to them and they end up signing the distributor an opportunistic way and often times they have the distributor register products and then the distributor owns the license for the approvals for those products and then when things aren't working out and they want to get out of it, then they have to realize that they have to start basically all over with the entire process.
00:08:07.730 --> 00:08:17.810
And so there've been a lot of disasters across Latin American, across Asia of people taking that sort of opportunistic approach and sometimes they get lucky and the distributed happened to contact them.
00:08:18.160 --> 00:08:20.709
It is in fact the best one for that geography.
00:08:20.711 --> 00:08:25.930
But I would say that oftentimes the more aggressive distributors are the ones that are less capable.
00:08:26.259 --> 00:08:43.570
I think companies should really spend some time on making sure they're doing that right and taking a step back, we usually start with international market prioritization on kind of a global view on that in which markets you should focus on or rich regions you should focus on within the regions then which markets you should focus on.
00:08:44.389 --> 00:08:45.750
Very well said, Kara.
00:08:45.769 --> 00:09:12.960
Actually, I once heard somebody, he's a CEO of a medical device company out of Israel and he told me once you know Julio, if you, you're the shooter around in a country or in a region like Latin America, you're going to have about three years of lost sales because you have to revise, you start the product, you have to find another shooter, you have to train this tutor and that is about three years to get everything back on track.
00:09:13.419 --> 00:09:16.740
Company shouldn't go through this if they do things right as you just described.
00:09:17.389 --> 00:09:30.169
Yeah, and I think the other thing that a lot of times people don't take into consideration their thinking about the business aspects of this, but the last time and then the reputation in the market because if you get with physicians, they start to engage with one distributor.
00:09:30.379 --> 00:09:34.429
Build a relationship with them is very, very disruptive to change distributors.
00:09:34.431 --> 00:09:37.220
And I think sometimes companies just think, oh, we'll wing it if it's not working out.
00:09:37.221 --> 00:09:39.860
Once you get a new distributor, it's not that simple.
00:09:39.919 --> 00:09:42.169
Ramifications can be disastrous.
00:09:42.171 --> 00:09:53.240
And there's some of these physicians in particular that really dominate certain specialties and uh, you don't manage it well and get off to a bad start with them and they're the leader of all the societies that are related.
00:09:53.570 --> 00:09:58.820
You may find yourself ostracized and incapable of ever building a commercially viable business in that country.
00:09:58.821 --> 00:10:04.620
So I think companies oftentimes, I don't appreciate the importance of getting it right from the beginning.
00:10:05.090 --> 00:10:09.899
And many of these markets are very unforgiving and hazard approaches can be quite disastrous.
00:10:10.379 --> 00:10:10.830
Sure.
00:10:10.950 --> 00:10:11.340
Yeah.
00:10:11.519 --> 00:10:11.820
Yeah.
00:10:12.360 --> 00:10:12.690
All right.
00:10:12.870 --> 00:10:18.899
So let's speak a little bit about how to find and conduct due diligence on the shooters.
00:10:19.029 --> 00:10:22.889
You already touched a little bit on that, but I'd like to get a little tapers with listeners.
00:10:23.159 --> 00:10:36.490
King have practical and actionable information for your character and also like to talk about the two approaches that you usually see companies in US companies trying to manage the shooters in Latin America.
00:10:36.549 --> 00:10:59.429
One approach that I see is that just to have a handoff management approach where they just sell products or distributor and let this shooter run the show on his own and were, the other approach that I see is a hybrid approach where they have of course local distributors and or sales agents in a country and they have a very, a strong support of that.
00:10:59.480 --> 00:11:10.289
The shooter, you know, they travel very frequently or they have somebody from Miami managing the shooter or they have a local person in the major markets like Brazil or Columbia or Mexico.
00:11:10.559 --> 00:11:13.139
So I'd like to get your take on these two topics.
00:11:13.140 --> 00:11:21.690
One is how to best find and conduct due diligence on the shooters and second, how to manage and support this shooter apps you use and a distribution agreement.
00:11:23.149 --> 00:11:34.730
Yeah, so I think with the distributor due diligence, I obviously don't like the haphazard approach of just waiting to see who comes to you and then picking the best from that lot because I don't believe that's probably a very effective way to do it.
00:11:35.000 --> 00:11:39.769
I think the best way is to engage, you know, local expertise is critical in certain geographies.
00:11:39.770 --> 00:11:42.559
I think a lot of American companies are very familiar with Europe.
00:11:42.649 --> 00:11:50.750
A lot of people have traveled to Europe very frequently and they probably don't see much value in necessarily in having some of these third parties help them.
00:11:50.750 --> 00:12:00.200
But I think with Latin America and Asia, it's really critical to, you don't have an understanding of those local markets understand how to assess effectively potential distributor options.
00:12:00.201 --> 00:12:05.509
And sometimes people think they marginalize or don't appreciate the importance of these considerations.
00:12:05.510 --> 00:12:16.129
So I think the best way is to find people, whether they be individuals or market access firms, find firms or individuals who have the local expertise and can help guide them through that process.
00:12:16.519 --> 00:12:19.879
And I think it's important for people to travel to the geography.
00:12:20.059 --> 00:12:28.070
A lot of times distribution deals will be done at international meetings in the U S and Europe for distribution products in Asia or Latin America.
00:12:28.071 --> 00:12:33.759
And I think it's important to go to a couple of the key conferences within the geography before you make a decision.
00:12:33.820 --> 00:12:56.980
You can tell a lot by the presence of that organization observing the dynamics between some of the Kol and the companies that you're considering and really get firsthand information and Intel and one thing that a lot of times people don't understand is the distinction between like a master distributor and the actual distributors out there with sales rep selling the product.
00:12:57.279 --> 00:13:18.250
I've seen so many scenarios and this happens quite a lot with Latin America as well, where companies will say, Oh, we've just done a distribution deal for all of Latin America through one company and sometimes I don't think they really appreciate how things work with these master distributors who then have individual distributors, sometimes multiple distributors in each country or distributor in each country.
00:13:18.639 --> 00:13:22.240
That seems in theory like a great way to do it and in some cases it does work.
00:13:22.539 --> 00:13:25.899
A lot of times they're not necessarily, you know, the best option.
00:13:25.900 --> 00:13:33.480
You really need to get on the ground and travel with local experts and get some real world intel on the firms that you're considering.
00:13:33.480 --> 00:13:37.980
I don't think you can really do proper due diligence purely based on looking at paper.
00:13:39.759 --> 00:13:40.720
Yeah, good point.
00:13:41.950 --> 00:13:54.529
And also just to elaborate a little bit on what you just said, because I think it's he here, I've heard from companies curve things like, oh my, the shooter in Brazil can cover Columbia, Ecuador, Peru.
00:13:54.860 --> 00:13:55.669
I mean, come on.
00:13:55.940 --> 00:13:58.399
These very truly different countries.
00:13:58.700 --> 00:14:10.009
It's not like in the u s where you have almost no borders between states, but in, in Latin America, you cannot really have a Pan American distributor that can cover more than one or two countries.
00:14:10.010 --> 00:14:10.730
It's just difficult.
00:14:10.730 --> 00:14:11.480
You don't really see that.
00:14:11.769 --> 00:14:25.840
But there are a lot of people who do that and I think I've seen that happen a number of times in the past when I was responsible for a lot in America, I had a lot of those master distributors contact me as how you can leave the whole of Latin America up to us from times he's busy.
00:14:25.841 --> 00:14:27.490
The folks that manage international.
00:14:27.490 --> 00:14:34.929
I know from my own experience, one year when I found myself in 22 different countries in one year you're slammed, you're busy, you're on the road all the time.
00:14:34.960 --> 00:14:40.450
There is a certain appeal to the simplicity of signing up one master distributor and letting them do it.
00:14:40.451 --> 00:14:47.090
But if you really want to optimize, and it is a case by case I guess decision, but I think in most cases it's probably not the optimal decision.
00:14:47.509 --> 00:15:02.320
And if you want to optimize a opportunity for your firm in the region, you're probably gonna need to contract individually with the distributors in each country and invest the time and going through, you know, a proper process for doing the due diligence on those firms.
00:15:03.279 --> 00:15:04.090
Yeah, absolutely.
00:15:04.120 --> 00:15:10.360
And also you have to take into conservation the fact that the masculine shooter adds a few points over the price of the product.
00:15:10.360 --> 00:15:12.490
So eventually the product gets more expensive.
00:15:12.850 --> 00:15:15.820
You have the master distributor, then you have the actual local distributor.
00:15:16.340 --> 00:15:17.350
There's really no need for that.
00:15:17.580 --> 00:15:17.870
So
00:15:18.149 --> 00:15:26.039
yeah, if you're going to leave the registration, the local registration up to the distributor, you also need to assess the regulatory capabilities of that distributor.
00:15:26.041 --> 00:15:40.289
I think that's another area where yeah, you get your very commercially minded sales person running it and they're looking purely at the sales capabilities when if you can't get through the regulatory process, there no value to having that.
00:15:40.291 --> 00:15:47.460
So while I don't usually believe that's the best way to go and don't want to get a situation where the distributors hold the licenses.
00:15:47.909 --> 00:15:52.679
If you are going to go that route, you definitely need to make that assessment as well.
00:15:52.681 --> 00:16:01.470
And then of course you need to assess the compliance aspects and again, you know the very experienced folks running international, they understand that very well.
00:16:01.620 --> 00:16:04.529
But in the case of startups, a lot of times you have people wearing a lot of hats.
00:16:04.530 --> 00:16:25.629
I mean their primary role might be you at marketing but because they are trying to stay lean and they find themselves also responsible for international distributors and sometimes they don't do their homework early on that and there is good processes and good tools out there for helping you to be able to, you know, assess the compliance of a, of the distributors.
00:16:26.929 --> 00:16:27.950
Sure, sure.
00:16:28.250 --> 00:16:28.519
All right.
00:16:28.700 --> 00:16:31.129
Let's talk about uh, how to manage distributors.
00:16:31.519 --> 00:16:43.230
Remember that we kind of touch on the idea of a hands off management approach versus a hybrid approach where you have a sales agent, we're a local office or something in the metro markets to support the work we use.
00:16:43.549 --> 00:16:43.549
Tutor.
00:16:43.700 --> 00:16:44.720
What's your take on these?
00:16:44.960 --> 00:16:49.620
I've been involved with that a lot over the last 26 years and it is somewhat case by case.
00:16:49.620 --> 00:16:59.070
I mean if you're dealing with a very specialized product where the market opportunity is small, you may not be able to justify having somebody in the region when it's feasible.
00:16:59.071 --> 00:17:01.080
I definitely prefer a hybrid approach.
00:17:01.429 --> 00:17:03.509
I'm not leaving everything up to the distributor.
00:17:03.720 --> 00:17:06.150
I mean there's a number of ways of being able to do that.
00:17:06.151 --> 00:17:10.920
Certainly you can set up a local office and hire people if that's not feasible.
00:17:11.130 --> 00:17:29.470
There's the kind of the training wheels step where you get a market access from to be able to act on your behalf, go to all the conferences, help facilitate the training and help facilitate the building of relationships with Kol and things and I think that's important because part of it is with dealing with distributors is is driving mind share.
00:17:29.869 --> 00:17:36.940
They've got however mini bag, get a product in their bag, maybe 20 other companies' products in their bag and which one are they going to pull out when they're in front of the customer.
00:17:37.359 --> 00:17:42.450
If you've got somebody in the region, they're traveling weekly with the distributor reps in that region.
00:17:43.000 --> 00:17:53.130
If your representative is standing right next to the distributor sales rep, yeah, it probably them pulling out your bag or your product from bag is of course much, much higher and as they know, in two weeks you're going to be traveling.
00:17:53.380 --> 00:17:56.920
Somebody from your company is going to be traveling to the region and traveling with their reps.
00:17:56.921 --> 00:17:58.259
Of course they're going to be pre-selling.
00:17:58.480 --> 00:18:05.589
It's and making the most of that, but if you're not present, if you're just signed a distribution agreement, send them some samples, do a web training.
00:18:05.740 --> 00:18:16.869
Those things aren't going to happen and quite a high probability that you're just gonna fall lower and lower on their priority as the companies that are doing those kinds of things are there and they're grabbing the mind share of the distributor and the distributor Reps.
00:18:17.609 --> 00:18:18.799
Yeah, well said.
00:18:18.900 --> 00:18:20.309
I mean, right on the point
00:18:20.579 --> 00:18:30.779
in my own experience, that's generally the way I ran it and you mentioned micros in my intro, we had multiple people working on the ground for us and we were probably on a good trajectory to overtake the number one.
00:18:30.970 --> 00:18:36.200
We're number two in the space and we were on a good trajectory and overtake the number one a player in that space.
00:18:36.201 --> 00:18:43.150
I when we got acquired byJ andJ and I think a lot of that was having people there locally, making things happen on a day to day basis.
00:18:43.151 --> 00:18:47.079
I was there much of the year and those I take are truly an investment.
00:18:47.080 --> 00:19:00.410
Obviously having he ad c o unts a nd having people on the ground is not an insignificant investment, but when the market opportunity is large and it's a highly technical sell, I' m l ike it is in that case in neuro, there's a great deal of value to having those people there.
00:19:01.829 --> 00:19:03.269
Yeah, very good point.
00:19:03.890 --> 00:19:07.140
[inaudible] and what about demand generation?
00:19:07.170 --> 00:19:10.049
Kirk, let's talk about that in a little more detail.
00:19:10.349 --> 00:19:23.079
I think based on what you just said, you are in favor of having somebody local working alongside the shooter to support the work and help the shooter generate demand.
00:19:23.380 --> 00:19:34.799
Have you ever been involved in situations like this where you've had to go directly to insurance companies or government agencies or hospitals to generate demand a directly should have?
00:19:34.910 --> 00:19:35.930
The sugar can fulfill it?
00:19:36.559 --> 00:19:36.559
Yeah.
00:19:36.579 --> 00:19:38.250
It's usually a kind of a hybrid approach.
00:19:38.259 --> 00:19:41.670
We're working really closely with the distributors to make those things happen.
00:19:41.859 --> 00:19:44.789
When you touched on the reimbursement authorities and absolutely.
00:19:44.849 --> 00:19:46.980
When I was working for companies, we did a lot of that.
00:19:46.980 --> 00:19:50.460
Our firm now does a lot to help support that process.
00:19:50.461 --> 00:20:00.319
Oftentimes we're working with specialized reimbursement firms, but I do a lot to support that process and be actively engaged in that process and I think that engagement can be very helpful.
00:20:00.410 --> 00:20:16.259
Again, that aspect, not every distributor is really great and working with hospital administration or working with a reimbursement authorities and if you have the bandwidth and the capability of being able to actively be a part of that process, it certainly would be the preferred approach.
00:20:17.299 --> 00:20:17.779
Very good.
00:20:18.170 --> 00:20:18.529
Okay.
00:20:19.130 --> 00:20:20.779
What about pricing curric?
00:20:20.839 --> 00:20:24.259
What's your perception of pricing in Latin America?
00:20:24.260 --> 00:20:27.470
I mean a lot of people say that Latin America is a price sensitive region.
00:20:28.099 --> 00:20:32.539
He has of course similarities with Asia and that's why I asked you this question.
00:20:32.660 --> 00:20:33.680
What's your take on this?
00:20:34.029 --> 00:21:09.400
Yeah, I mean I think overall the perception certainly is that price sensitive region, but having said that, I think that there are a number of companies out there that have managed to sell their product quite good price points relative to other markets and sometimes they just have to focus on the South Pei segment of the market or the private insurance segment of the market that you may not be able to address the entire market in some cases, but not, yeah, I wouldn't say it's not every case where prices are low and they certainly trend to be lower than a lot of the other geographies, but I don't think companies should immediately assume their prices are too low.
00:21:09.401 --> 00:21:20.119
I think it's definitely worth it to do that diligence and really get a handle on the market and like I said, sometimes you have to forego, you know, the entire market and really focus on segments of the market.
00:21:20.700 --> 00:21:21.059
Okay.
00:21:21.589 --> 00:21:21.859
Okay.
00:21:22.069 --> 00:21:22.579
Good point.
00:21:23.359 --> 00:21:23.809
All right.
00:21:23.990 --> 00:21:27.019
What about the importation process, Kurt?
00:21:27.170 --> 00:21:32.089
Of course your experiences in Asia, but again, leveraging of the similarities of the two regions.
00:21:32.900 --> 00:21:34.369
Any tips on that?
00:21:34.371 --> 00:21:37.609
Any practical advice you can give listeners from that?
00:21:38.049 --> 00:21:40.240
On what aspect of importation
00:21:40.990 --> 00:21:41.529
in general?
00:21:41.530 --> 00:21:48.609
I mean it's dealing with costume agencies, paperwork and he got just any headsup.
00:21:49.859 --> 00:21:50.269
Yeah, yeah.
00:21:50.559 --> 00:21:53.210
If you're dealing with the distributor, they should be able to handle that.
00:21:53.759 --> 00:21:53.759
No.
00:21:53.760 --> 00:22:05.759
If you're gearing up for a first in man and you don't have a distributor at that point, then I think there are certainly specialized firms like yourselves who have that expertise and who understand how to navigate those processes.
00:22:06.200 --> 00:22:20.000
I think in general, from my perspective, when we're talking about some of the key countries in Asia war, Latin America, is the importance of that local expertise and not being afraid or[inaudible] willingness to invest in getting help to ensure that things go well.
00:22:20.720 --> 00:22:21.140
Very good.
00:22:21.289 --> 00:22:21.650
Yeah.
00:22:22.039 --> 00:22:46.339
I even heard from about three guests on the podcast, did they suggest that the shipper, that companies do not handle the shipment of the products directly because they may not have the experience shipping to a particular country because every country, you know, has certain forms, certain regulations and how the products are classified and things of that nature.
00:22:46.549 --> 00:22:58.420
So they guessed that I'm speaking about specifically suggest companies to hire or contract the services of a third party shipping company to has practical experience in this specific country.
00:22:58.839 --> 00:23:00.430
Where are they going to ship products to?
00:23:00.700 --> 00:23:04.599
Yes, to avoid any issues and from there there's a shooter will take over.
00:23:04.869 --> 00:23:23.269
Sometimes the distributor who has an office in Miami, the case of Latin America, and you just ship domestically from your location in the u s to Miami and the shooter will handle the rest, but in some cases that's not feasible, so you have to ship directly to a country and you need the help of an expert.
00:23:23.329 --> 00:23:24.720
Shipper offered that.
00:23:25.519 --> 00:23:25.519
Yeah.
00:23:25.520 --> 00:23:28.740
I think that there's probably a lot of situations where that's the case.
00:23:28.740 --> 00:23:38.009
I think in my experience and when we've done some early cases in Asia, we've often times work with specialized firms to help facilitate the import of that product.
00:23:38.010 --> 00:23:52.309
In the case of Japan, sometimes we'll find that we'll have a client who's doing cases where the physician is important on their medical license and it's the physician's responsibility, but it's still very helpful to the physician and to everybody involved too.
00:23:52.619 --> 00:24:05.940
Engage a firm that has that expertise and they can make sure that the process goes smoothly, make sure they're asking for all the right information so that when product does get shipped and it arrives in customs, everything is in order and it can pass through smoothly.
00:24:05.950 --> 00:24:14.759
And there's no delay in not doing the cases and any cases where we're doing these types of import, it's for critical stuff that's not available in the market.
00:24:14.940 --> 00:24:19.109
It's not currently commercially available, so it can be life and death circumstances.
00:24:19.111 --> 00:24:27.720
And so doing it in a haphazard way where it gets stuck in customs because something's not filled out properly, can have substantial impact on the patients and their outcomes.
00:24:27.721 --> 00:24:35.000
So I don't think people should take that lightly and assume that they can take care of everything themselves, but rather to make sure it's done well.
00:24:35.099 --> 00:24:40.200
Particularly for products where a patient may have tubular disease that the treatment of witches is urgent.
00:24:40.950 --> 00:24:41.490
Good answer.
00:24:42.190 --> 00:24:42.190
Correct.
00:24:42.430 --> 00:24:55.259
All right, so let's move along here and speak about your experience with[inaudible] corruption or bribery in Asia in light of the Foreign Corrupt Practices Act of 1977
00:24:55.980 --> 00:25:10.259
yeah, I think that going back to what we're talking about with compliance, it is really critical when you're picking distributors to do very thorough due diligence on this and transparency index and various indicators of probably how much emphasis you should put on certain markets.
00:25:10.529 --> 00:25:14.460
There are markets that are notoriously transparent and not corrupt.
00:25:14.461 --> 00:25:26.730
Some of the Scandinavian countries come to mind in New Zealand and there some others that are known for a low level of corruption and there are others that are known to have a very, very high level or the level of emphasis or resources you should put into the due diligence.
00:25:27.150 --> 00:25:40.359
It should have a lot to do with where they fall on the corruption index and for some of the more corrupt countries, you should absolutely make sure that it's going to cost you extra, but you make that extra investment to ensure that the distributors that you do select are compliant.
00:25:40.819 --> 00:25:49.559
Because you know, if you look back in the history of medical devices, there have been a lot of issues with compliance across the world and it's not just limited to emerging markets.